Analysis of Key Market Segments Influencing the Post-Marketing Pharmacovigilance and Medical Information Market

The landscape of post-marketing pharmacovigilance and medical information is evolving rapidly, driven by technological advancements and increasing demands for drug safety monitoring. This sector is poised for significant growth, supported by innovations that improve how adverse drug reactions are detected and managed after products reach the market. Let's explore the market's size, key players, trends, and segmentation to better understand its future trajectory.

Anticipated Market Size and Growth for Post-Marketing Pharmacovigilance and Medical Information
The post-marketing pharmacovigilance and medical information market is set to experience substantial expansion, reaching a value of $11.89 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 11.4%. Several factors are driving this upward trend, including the integration of artificial intelligence (AI) and machine learning (ML) algorithms for more effective signal detection. Additionally, the use of longitudinal patient data analysis, wider deployment of disease registry-linked monitoring systems, increased reporting through digital apps, and growing investments in real-time pharmacovigilance technologies contribute significantly. Notable trends shaping this market include the growing adoption of electronic health record (EHR) mining, the expanded use of real-time adverse drug reaction (ADR) monitoring technologies, the rise of risk population and therapeutic class-based reporting methods, enhanced cohort event monitoring for new drug users, and the integration of mobile and digital platforms for streamlined pharmacovigilance reporting.

Download a free sample of the post-marketing pharmacovigilance and medical information market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Organizations in the Post-Marketing Pharmacovigilance and Medical Information Sector
Several prominent companies play a vital role in this market, including accenture* plc, Sanofi S.A., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, ICON plc, Syneos Health Inc., Genpact Limited, Parexel International Corporation, Avalere Health LLC, Quanticate Limited, and Inizio Consulting LLC.
In a strategic move to strengthen its position, Ergomed plc, a UK-based pharmaceutical services firm, acquired Panacea Pharma Projects Limited in October 2023. This acquisition is designed to expand Ergomed's pharmacovigilance branch, PrimeVigilance, enhancing its service capabilities and geographic presence. Panacea Pharma Projects Limited specializes in pharmacovigilance and medical information services, particularly post-marketing support, making it a valuable addition to Ergomed's portfolio.

Emerging Innovations Enhancing Post-Marketing Pharmacovigilance
Companies in this market are increasingly focusing on AI-driven solutions to improve the accuracy and efficiency of adverse event detection. AI-powered pharmacovigilance workflows streamline drug safety monitoring by automating processes to deliver faster and more reliable results. This technology also supports real-time safety surveillance, which is crucial for better patient outcomes.
For example, in January 2024, PubHive Ltd., a UK-based cloud SaaS provider, launched a centralized Summary of Product Characteristics (SmPC) management platform targeted at life science companies and research organizations. The platform consolidates essential drug safety data into a unified repository, automates literature monitoring and regulatory reporting, fosters enhanced team collaboration, and simplifies compliance activities through sophisticated AI features. This innovation enables pharmacovigilance teams to act more proactively and efficiently, ensuring patient safety and regulatory adherence.

View the full post-marketing pharmacovigilance and medical information market report:
https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Detailed Market Segmentation and Forecast in Post-Marketing Pharmacovigilance and Medical Information
This market is segmented by type, publication format, and end user to provide a clear picture of its structure:
1) Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining
2) Publication Type: Books, Online Media, Journals
3) End User: Hospitals, Research Organizations, Other End-Users
Further breakdowns include:
- Spontaneous Reporting divided into consumer, healthcare professional, regulatory authority, pharmaceutical company, and digital app-based reporting
- Intensified ADR Reporting consisting of hospital-based surveillance, program-specific, disease-specific, product-specific, and real-time monitoring systems
- Targeted Spontaneous Reporting covering risk population, therapeutic class, ADR-focused, region-specific, and healthcare setting-specific reporting
- Cohort Event Monitoring split into prospective, retrospective, active follow-up, new drug user, and disease registry-linked monitoring
- Electronic Health Record Mining utilizing natural language processing, AI and ML algorithms, rule-based signal detection, longitudinal patient data analysis, and integrated hospital data systems

This segmentation highlights the complexity and breadth of the post-marketing pharmacovigilance and medical information market, emphasizing the diverse methods and tools used to ensure drug safety and regulatory compliance worldwide.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.